Correlation Between Sligro Food and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sligro Food and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sligro Food and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sligro Food Group and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Sligro Food and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sligro Food with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sligro Food and Centessa Pharmaceuticals.
Diversification Opportunities for Sligro Food and Centessa Pharmaceuticals
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Sligro and Centessa is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Sligro Food Group and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Sligro Food is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sligro Food Group are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Sligro Food i.e., Sligro Food and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sligro Food and Centessa Pharmaceuticals
Assuming the 90 days horizon Sligro Food Group is expected to under-perform the Centessa Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Sligro Food Group is 2.53 times less risky than Centessa Pharmaceuticals. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Centessa Pharmaceuticals PLC is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 803.00 in Centessa Pharmaceuticals PLC on September 25, 2024 and sell it today you would earn a total of 891.00 from holding Centessa Pharmaceuticals PLC or generate 110.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sligro Food Group vs. Centessa Pharmaceuticals PLC
Performance |
| Timeline |
| Sligro Food Group |
| Centessa Pharmaceuticals |
Sligro Food and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sligro Food and Centessa Pharmaceuticals
The main advantage of trading using opposite Sligro Food and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sligro Food position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.| Sligro Food vs. Chewy Inc | Sligro Food vs. RadNet Inc | Sligro Food vs. Fast Retailing Co | Sligro Food vs. BioNTech SE |
| Centessa Pharmaceuticals vs. Fate Therapeutics | Centessa Pharmaceuticals vs. Caribou Biosciences | Centessa Pharmaceuticals vs. Karyopharm Therapeutics | Centessa Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |